Collegium Pharmaceutical, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Collegium Pharmaceutical, Inc. (COLL) had Common Stock, Capital Shares Reserved for Future Issuance of 7.19 million shares as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2020-02-27
- 2019-12-31: Common Stock, Capital Shares Reserved for Future Issuance 7.19M shares.
- 2018-12-31: Common Stock, Capital Shares Reserved for Future Issuance 6.54M shares.
- 2017-12-31: Common Stock, Capital Shares Reserved for Future Issuance 6.54M shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 4.70M shares.
- 2016-12-31: Common Stock, Capital Shares Reserved for Future Issuance 4.70M shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 3.71K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2019-12-31 | 7.19M shares 10-K · filed 2020-02-27 | |
| 2018-12-31 | 6.54M shares 10-K · filed 2020-02-27 | |
| 2017-12-31 | 6.54M shares 10-K · filed 2019-02-27 | 4.70M shares 10-K · filed 2018-03-07 |
| 2016-12-31 | 4.70M shares 10-K · filed 2019-02-27 | 3.71K shares 10-K · filed 2017-03-10 |
| 2015-12-31 | 2.84K shares 10-K · filed 2017-03-10 | |
| 2014-12-31 | 21.93K shares 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |